Used primarily as an intermediate in the synthesis of proton pump inhibitors (PPIs), this compound serves as a key precursor in the development of medications that reduce stomach acid production. It is especially valuable in the manufacturing of drugs used to treat gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related gastrointestinal disorders. Derivatives of this chemical, such as certain PPIs, selectively target the H+/K+ ATPase enzyme system in the gastric parietal cells, contributing to long-lasting acid suppression. The structural features of this intermediate enable optimized stability and bioavailability in the final drug formulations, making it a preferred choice in the design of effective anti-ulcer medications.